$8.320
-0.345 (-4.15%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Atrium Therapeutics Inc (RNA) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting RNA is Sell.
Atrium Therapeutics Inc (RNA) 20-Day simple moving average is 8.15, while Atrium Therapeutics Inc (RNA) share price is $—, making it Buy.
Atrium Therapeutics Inc (RNA) 60-Day simple moving average is 10.01, while Atrium Therapeutics Inc (RNA) share price is $—, making it Sell.
Technical Analysis for RNA
AI Technical RNAAs of 2026-11-03, the technical board for Atrium Therapeutics Inc (RNA) reads sell: 3 indicators are flashing buy, 6 are indicating sell, and 4 are neutral. Price at $8.32 sits below the 5-day, 10-day, 60-day and 200-day moving averages and above the 20-day.
Momentum readings: RSI stands at 45.833, MACD stands at -0.14 (Sell), Stochastic %K stands at 76.92, Stochastic %D stands at 83.587 and CCI stands at 78.54.
RNA trades below the 60-day SMA (10.01) and below the 200-day SMA (19.59). Immediate resistance sits at Classic R1 8.98, then R2 9.59. Support sits at Classic S1 7.77, then S2 7.17.
Atrium Therapeutics Inc (RNA) Support & Resistance Level
Atrium Therapeutics Inc (RNA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 45.833 |
| STOCHk_14_3_3 | 76.920 |
| STOCHd_14_3_3 | 83.587 |
| CCI_20 | 78.540 |
| AO_5_34 | 0.230 |
| MOM_10 | 0.160 |
| MACD_12_26_9 | -0.140 |
Atrium Therapeutics Inc (RNA) Relative Strength Index (RSI_14) is 45.833, creating a Neutral signal.
Atrium Therapeutics Inc (RNA) Stochastic %K is 76.920, creating a Neutral signal.
Atrium Therapeutics Inc (RNA) Stochastic %D is 83.587, creating a Sell signal.
Atrium Therapeutics Inc (RNA) CCI_20 is 78.540, creating a Neutral signal.
Atrium Therapeutics Inc (RNA) Awesome Oscillator (AO) is 0.230, creating a Buy signal.
Atrium Therapeutics Inc (RNA) Momentum (MOM) is 0.160, creating a Buy signal.
Atrium Therapeutics Inc (RNA) Moving Average Convergence Divergence (MACD) is -0.140, creating a Sell signal.
Atrium Therapeutics Inc (RNA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 8.508 | Sell |
| MA_10 | 8.377 | Sell |
| MA_20 | 8.153 | Buy |
| MA_60 | 10.013 | Sell |
| MA_200 | 19.593 | Sell |
| MA_250 | 29.998 | Sell |
Atrium Therapeutics Inc (RNA) 5-Day simple moving average is 8.508, while Atrium Therapeutics Inc (RNA) share price is $, making it a Sell.
Atrium Therapeutics Inc (RNA) 10-Day simple moving average is 8.377, while Atrium Therapeutics Inc (RNA) share price is $, making it a Sell.
Atrium Therapeutics Inc (RNA) 20-Day simple moving average is 8.153, while Atrium Therapeutics Inc (RNA) share price is $, making it a Buy.
Atrium Therapeutics Inc (RNA) 60-Day simple moving average is 10.013, while Atrium Therapeutics Inc (RNA) share price is $, making it a Sell.
Atrium Therapeutics Inc (RNA) 200-Day simple moving average is 19.593, while Atrium Therapeutics Inc (RNA) share price is $, making it a Sell.
Atrium Therapeutics Inc (RNA) 250-Day simple moving average is 29.998, while Atrium Therapeutics Inc (RNA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.